![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Asia Pacific Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)
Market Introduction
The APAC Pharmaceutical Isolator Market is sub-segmented into five major countries: China, Japan, India, Australia, South Korea, and the Rest of APAC. The market in the region is largely held by countries such as China and Japan. In the Asia Pacific, China is the largest market for biopharmaceutical pharmaceutical isolator market. The growth of the market is primarily attributed to the established pharmaceutical market, increasing R&D expenditures by the pharmaceutical and biopharmaceutical companies, and favorable regulatory policies. China has the world’s second-largest pharmaceutical market. The excessive population in China, coupled with the rise of various communicable and non-communicable diseases, are majorly driving the growth of the pharmaceutical companies in China and making it a prime market in the Asia Pacific region. For instance, the outbreak of the Coronavirus in China led to the launch of several drugs to counter the coronavirus (Covid-19). It has increased contract manufacturing in the country, leading to the growth of the market. Burgeoning adoption of automation in pharmaceutical isolator and escalating pharmaceutical and biotechnological industries are the major factor driving the growth of the APAC pharmaceutical isolator market
In case of COVID-19, APAC is highly affected specially India. The APAC biopharmaceutical industry has been disturbed for few months of 2020 during the outbreak of the COVID-19 pandemic. However, with the rising demand for products to treat the COVID-19 infection, the biopharmaceutical, and pharmaceutical companies in the countries such as India and China have increased their production of APIs as the countries are the largest exporters to western companies. For instance, Wockhardt Ltd is in talks with the Indian government to offer its sterile development facility for the covid-19 vaccines that will be developed in the country, as well as with some firms whose vaccines are currently in phase I/II trials globally. Moreover, on 07 May 2020, Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services with sites in Belgium, United States, Japan, and India, announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late-stage biotechnology company, for the supply of the investigational new drug, leronlimab (PRO 140), which is currently being used in clinical trial protocols for Mild-to-Moderately Ill and Severely Ill COVID-19 patients. The countries are experiencing growth in biologics production also; there is growth in the contract manufacturing for biopharmaceutical and pharmaceutical products. For instance, in January 2020, STA Pharmaceutical Co., Ltd. (WuXi AppTec) has expanded its oligonucleotide API manufacturing in China. Similarly, companies have engaged in the production of vaccines and have sent them to clinical trials. For instance, in Japan, Gilead's Remdesivier and Fujifilm's antiviral Avigan are in Phase III clinical trials. Thus, with the growing production by the biopharmaceutical industry, the pharmaceutical isolators market is likely to have vital growth opportunities in the following years.
![](https://www.theinsightpartners.com//assets/rdimages/25278-img1.png)
Get more information on this report :
Market Overview and Dynamics
The APAC pharmaceutical isolator market is expected to grow from US$ 1,060.82 million in 2021 to US$ 1,975.83 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028. Several big and small pharmaceutical companies are engaged in the development and manufacturing of new and novel molecules for life-threatening conditions. Pharmaceutical isolator systems have been regarded as a key technology in the drug discovery process. Thus, the adoption of pharmaceutical isolators is increasing to ensure contamination-free manufacturing and product handling. The pharmaceutical isolator provides safety to an operator from the exposure of harmful drugs, eliminates the possibilities of cross-contamination, and maintains the standard of drug quality. In the pharmaceutical industry, it is extremely important to maintain immense caution during the product manufacturing process. Different types of isolators are available in the pharmaceutical market that provide an optimum level of sterility in the product manufacturing process. The handling of pharmaceuticals with high potency ingredients, such as hormones and antibiotics. Biologic drugs need a greater level of precautions. Pharma and biotech companies have substantially invested in pharmaceutical isolator techniques in the past decade. Growing investments by pharmaceutical and biotechnology companies and extensive drug pipelines for the treatment of various chronic diseases, such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders, are the prominent drivers for the growth of the APAC pharmaceutical isolator market.
Key Market Segments
In terms of type, the open isolator segment accounted for the largest share of the APAC pharmaceutical isolator market in 2020. In terms of pressure, the positive pressure segment held a larger market share of the APAC pharmaceutical isolator market in 2020. In terms of configuration, the floor standing segment held a larger market share of the APAC pharmaceutical isolator market in 2020. In terms of application, the aseptic isolators segment held a larger market share of the APAC pharmaceutical isolator market in 2020. Further, the pharmaceutical and biotechnology companies segment held a larger share of the APAC pharmaceutical isolator market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the APAC pharmaceutical isolator market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Azbil Telstar, Bioquell (Ecolab Solution), Comecer, Fedegari Autoclavi S.p.A., Gelman Singapore, Getinge AB, Hosokawa Micron Group, Nuaire Inc., and Schematic Engineering Industries.
Reasons to buy report
- To understand the APAC pharmaceutical isolator market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC pharmaceutical isolator market
- Efficiently plan M&A and partnership deals in APAC pharmaceutical isolator market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC pharmaceutical isolator market
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.
APAC Pharmaceutical Isolator Market Segmentation
APAC Pharmaceutical Isolator Market - By Type
- Open Isolators
- Closed Isolators
APAC Pharmaceutical Isolator Market - By Pressure
- Positive Pressure
- Negative Pressure
APAC Pharmaceutical Isolator Market - By Configuration
- Floor Standing
- Modular
- Compact
- Mobile
APAC Pharmaceutical Isolator Market - By Application
- Aseptic
- Sampling & Weighing
- Fluid Dispensing
- Containment
- Others
APAC Pharmaceutical Isolator Market – By End User
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research and Academic Laboratories
- Other
APAC Pharmaceutical Isolator Market - By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
APAC Pharmaceutical Isolator Market - Company Profiles
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Gelman Singapore
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
- Schematic Engineering Industries
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Pharmaceutical Isolator Market – By Type
1.3.2 APAC Pharmaceutical Isolator Market – By Pressure
1.3.3 APAC Pharmaceutical Isolator Market – By Configuration
1.3.4 APAC Pharmaceutical Isolator Market – By Application
1.3.5 APAC Pharmaceutical Isolator Market – By End User
1.3.6 APAC Pharmaceutical Isolator Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Pharmaceutical Isolator Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging investments by Pharmaceutical and Biotechnology Industry
5.1.2 Structure to Support Adoption of Pharmaceutical Isolators
5.2 Market Restraint
5.2.1 Overpriced Operation and Maintenance
5.3 Market Opportunities
5.3.1 Escalating Pharmaceutical and Biotechnological Industries
5.4 Future Trends
5.4.1 Burgeoning Adoption of Automation in Pharmaceutical Isolator
5.5 Impact Analysis
6. Pharmaceutical Isolator Market – APAC Analysis
6.1 APAC Pharmaceutical Isolator Market Revenue Forecast and Analysis
7. APAC Pharmaceutical Isolator Market Analysis and forecasts to 2028 –By Type
7.1 Overview
7.2 APAC Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)
7.3 Open Isolator
7.3.1 Overview
7.3.2 Open Isolator Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Closed Isolator
7.4.1 Overview
7.4.2 Closed Isolator Market Revenue and Forecast to 2028 (US$ Mn)
8. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Pressure
8.1 Overview
8.2 APAC Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)
8.3 Positive Pressure
8.3.1 Overview
8.3.2 Positive Pressure Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Negative Pressure
8.4.1 Overview
8.4.2 Negative Pressure Market Revenue and Forecast to 2028 (US$ Mn)
9. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Configuration
9.1 Overview
9.2 APAC Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)
9.3 Floor Standing
9.3.1 Overview
9.3.2 Floor Standing Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Modular
9.4.1 Overview
9.4.2 Modular Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Compact
9.5.1 Overview
9.5.2 Compact Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Mobile
9.6.1 Overview
9.6.2 Mobile Market Revenue and Forecast to 2028 (US$ Mn)
10. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Application
10.1 Overview
10.2 APAC Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)
10.3 Aseptic Isolators
10.3.1 Overview
10.3.2 Aseptic Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Sampling and Weighing Isolators
10.4.1 Overview
10.4.2 Sampling and Weighing Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Fluid Dispensing Isolators
10.5.1 Overview
10.5.2 Fluid Dispensing Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Containment Isolators
10.6.1 Overview
10.6.2 Containment Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By End User
11.1 Overview
11.2 APAC Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)
11.3 Pharmaceuticals and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical And Biotechnology Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Research and Academic Laboratories
11.5.1 Overview
11.5.2 Research and Academic Laboratories Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. APAC Pharmaceutical Isolator Market – Country Analysis
12.1 APAC: Pharmaceutical Isolator Market
12.1.1 Overview
12.1.2 APAC: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)
12.1.2.1 China: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 China: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 China: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.3 China: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.4 China: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.5 China: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.6 China: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
12.1.2.2 Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 Japan: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.3 Japan: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.4 Japan: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.5 Japan: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.6 Japan: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
12.1.2.3 India: Pharmaceutical Isolator Market - Revenue and Forecasts to 2028 (USD Million)
12.1.2.3.1 India: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 India: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.3 India: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.4 India: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.5 India: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.6 India: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
12.1.2.4 South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 South Korea: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.3 South Korea: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.4 South Korea: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.5 South Korea: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.6 South Korea: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
12.1.2.5 Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.1 Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.2 Australia: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.3 Australia: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.4 Australia: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.5 Australia: Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.6 Australia: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
12.1.2.6 Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.1 Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.2 Rest of APAC: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.3 Rest of APAC: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.4 Rest of APAC: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.5 Rest of APAC: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.6.6 Rest of APAC: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
13. Impact of COVID-19 Pandemic on APAC Pharmaceutical Isolator Market
13.1 APAC: Impact Assessment of COVID-19 Pandemic
14. Industry Landscape
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. Company Profiles
15.1 Schematic Engineering Industries
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Nuaire Inc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Comecer
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Getinge AB
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 Hosokawa Micron Group
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Fedegari Autoclavi S.p.A.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Azbil Telstar
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Gelman Singapore
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Bioquell ( Ecolab Solution)
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Table 2. China Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 4. China Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 5. China Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. China Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Pharmaceutical Isolator Market , by Application, – Revenue and Forecast to 2028 (USD Million)
Table 11. Japan Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. India: R&D spending of Pharmaceutical companies (2010 & 2017)
Table 13. India Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. India Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 15. India Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 16. India Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. India Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 23. Australia Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 24. Australia Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 26. Australia Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 27. Australia Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of APAC Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of APAC Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of APAC Pharmaceutical Isolator Market , by configuration – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of APAC Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of APAC Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 33. Organic Developments Done By Companies
Table 34. Inorganic Developments Done by Companies
Table 35. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Pharmaceutical Isolator Market Segmentation
Figure 2. APAC Pharmaceutical Isolator Market Segmentation, By Country
Figure 3. APAC Pharmaceutical Isolator Market Overview
Figure 4. Open Isolators Segment led the Market in 2021
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Pharmaceutical Isolator Market Impact Analysis of Driver and Restraints
Figure 8. APAC Pharmaceutical Isolator Market – Revenue Forecast and Analysis
Figure 9. APAC Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)
Figure 10. APAC Open Isolator Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. APAC Closed Isolator Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. APAC Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)
Figure 13. APAC Positive Pressure Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. APAC Negative Pressure Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. APAC Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)
Figure 16. APAC Floor Standing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. APAC Modular Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. APAC Compact Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. APAC Mobile Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. APAC Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)
Figure 21. APAC Aseptic Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. APAC Sampling and Weighing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. APAC Fluid Dispensing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. APAC Containment Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. APAC Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. APAC Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)
Figure 27. APAC Pharmaceutical and Biotechnology Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. APAC Research and Academic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. APAC Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. APAC: Pharmaceutical Isolator Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. APAC: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)
Figure 33. China Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. India: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in APAC Country Markets
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Gelman Singapore
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
- Schematic Engineering Industries
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC pharmaceutical isolator market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in APAC pharmaceutical isolator market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the pharmaceutical isolator market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution